Malignant ventricular arrhythmias in alcoholic cardiomyopathy

被引:20
|
作者
Guzzo-Merello, Gonzalo [1 ,2 ]
Dominguez, Fernando [1 ]
Gonzalez-Lopez, Esther [1 ,3 ]
Cobo-Marcos, Marta [1 ]
Gomez-Bueno, Manuel [1 ]
Fernandez-Lozano, Ignacio [4 ]
Millan, Isabel [5 ]
Segovia, Javier [1 ]
Alonso-Pulpon, Luis [1 ]
Garcia-Pavia, Pablo [1 ,3 ]
机构
[1] Hosp Univ Puerta de Hierro, Dept Cardiol, Heart Failure & Inherited Cardiac Dis Unit, Madrid 28222, Spain
[2] Hosp Gen Villalba, Dept Cardiol, Madrid, Spain
[3] CNIC, Myocardial Biol Programme, Madrid, Spain
[4] Hosp Univ Puerta de Hierro, Dept Cardiol, Arrhythmia Unit, Madrid 28222, Spain
[5] Hosp Univ Puerta de Hierro, Biostat Unit, Madrid 28222, Spain
关键词
Alcohol; Arrhythmia; Alcoholic cardiomyopathy; Sudden cardiac death; IDIOPATHIC DILATED CARDIOMYOPATHY; SUDDEN CARDIAC DEATH; HEART-FAILURE; CONSUMPTION; HEALTH; ABUSE; RISK;
D O I
10.1016/j.ijcard.2015.07.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Excessive alcohol consumption is a well-known aetiology of atrial arrhythmias but there is little information concerning the prevalence or incidence of malignant ventricular arrhythmias in alcoholic cardiomyopathy (ACM). This study sought to investigate incidence and predictive factors of ventricular arrhythmias in ACM. Methods: Retrospective observational study of the clinical characteristics and long-term arrhythmic events in 282 consecutive patients with ACM(94 individuals) and idiopathic dilated cardiomyopathy (IDCM) (188 individuals) evaluated between 1993 and 2011. Results: During a median follow-up of 38 months (IQR: 12-77), 42 patients died and 79 underwent heart transplantation [31 (33%) with ACM vs 90 (48%) with IDCM; p = 0.017]. A total of 37 (13%) patients [18 (19%) ACM vs 20 (11%) IDCM; p = 0.048] suffered malignant ventricular arrhythmias. On multivariate analysis, left bundle branch block (LBBB) (OR 2.4; CI95%: 1.2-5; p = 0.015) and alcoholic aetiology (OR 2.3; CI95%: 1.1-4.5; p = 0.026) were the only independent predictors of malignant ventricular arrhythmic events. A total of 18 (19%) ACM patients experienced 20 malignant ventricular arrhythmic events (4 aborted SCD, 8 SCD and 8 appropriate ICD therapies). At baseline evaluation, the only independent predictor of malignant ventricular arrhythmias in ACM patients was LBBB (OR 11.2; CI95%: 2.6-50; p = 0.001). No malignant ventricular arrhythmias were recorded during follow-up in ACM patients if left ventricular ejection fraction (LVEF) had increased or remained >= 40%. Conclusions: Malignant ventricular arrhythmias are more frequent in ACM than in IDCM. LBBB identifies ACM patients with increased risk of SCD. No malignant ventricular arrhythmias were found during follow-up in ACM patients when LVEF was >= 40%. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 50 条
  • [31] PROPAFENONE FOR THE TREATMENT OF MALIGNANT VENTRICULAR ARRHYTHMIAS
    FRIEHLING, TD
    STOHLER, JL
    MARINCHAK, RA
    YEAGER, LA
    KOWEY, PR
    CLINICAL RESEARCH, 1987, 35 (05): : A786 - A786
  • [32] Mapping and ablation of malignant ventricular arrhythmias
    Hocini, M
    Jais, P
    Sacher, F
    Reuter, S
    Clémenty, J
    Haïssaguerre, M
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2005, 98 : 34 - 41
  • [33] THE INEFFECTIVENESS OF MEXILETINE FOR MALIGNANT VENTRICULAR ARRHYTHMIAS
    WESTVEER, DC
    STEWART, J
    GORDON, S
    TIMMIS, GC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (02) : 699 - 699
  • [34] EFFICACY OF MORICIZINE IN MALIGNANT VENTRICULAR ARRHYTHMIAS
    HOROWITZ, LN
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (08): : D41 - D46
  • [35] PROPAFENONE FOR THE TREATMENT OF MALIGNANT VENTRICULAR ARRHYTHMIAS
    KOWEY, PR
    STOHLER, JL
    FRIEHLING, TD
    MARINCHAK, RA
    YEAGER, LA
    CIRCULATION, 1987, 76 (04) : 521 - 521
  • [36] Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
    Turrini, P
    Angelini, A
    Thiene, G
    Buja, G
    Daliento, L
    Rizzoli, G
    Nava, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (08): : 1214 - 1219
  • [37] VENTRICULAR ARRHYTHMIAS IN DILATED CARDIOMYOPATHY - EFFICACY OF AMIODARONE
    NERI, R
    MESTRONI, L
    SALVI, A
    PANDULLO, C
    CAMERINI, F
    AMERICAN HEART JOURNAL, 1987, 113 (03) : 707 - 715
  • [38] Catheter ablation of ventricular arrhythmias in left ventricular noncompaction cardiomyopathy
    Sanchez Munoz, Juan Jose
    Munoz-Esparza, Carmen
    Penafiel Verdu, Pablo
    Martinez Sanchez, Juan
    Garcia Almagro, Francisco
    Elvira Ruiz, Gines
    Gimeno Blanes, Juan Ramon
    Garcia Alberola, Arcadio
    HEART RHYTHM, 2021, 18 (04) : 545 - 552
  • [39] Correlation of Ventricular Arrhythmias With Genotype in Arrhythmogenic Right Ventricular Cardiomyopathy
    Bao, Jingru
    Wang, Jizheng
    Yao, Yan
    Wang, Yilu
    Fan, Xiaohan
    Sun, Kai
    He, Ding Sheng
    Marcus, Frank I.
    Zhang, Shu
    Hui, Rutai
    Song, Lei
    CIRCULATION-CARDIOVASCULAR GENETICS, 2013, 6 (06): : 552 - 556
  • [40] SIGNIFICANCE OF VENTRICULAR ARRHYTHMIAS IN IDIOPATHIC DILATED CARDIOMYOPATHY
    MEINERTZ, T
    HOFMANN, T
    KASPER, W
    TREESE, N
    BECHTOLD, H
    STIENEN, U
    POP, T
    LEITNER, ERV
    ANDRESEN, D
    MEYER, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (07): : 902 - 907